Cargando…

Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis

The American Urological Association guidelines for the management of non-neurogenic overactive bladder (OAB) recommend the use of OnabotulinumtoxinA, sacral neuromodulation (SNM), and peripheral tibial nerve stimulation (PTNS) as third line treatment options with no treatment hierarchy. The current...

Descripción completa

Detalles Bibliográficos
Autores principales: Lo, Chi-Wen, Wu, Mei-Yi, Yang, Stephen Shei-Dei, Jaw, Fu-Shan, Chang, Shang-Jen
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077313/
https://www.ncbi.nlm.nih.gov/pubmed/32085542
http://dx.doi.org/10.3390/toxins12020128
_version_ 1783507404610076672
author Lo, Chi-Wen
Wu, Mei-Yi
Yang, Stephen Shei-Dei
Jaw, Fu-Shan
Chang, Shang-Jen
author_facet Lo, Chi-Wen
Wu, Mei-Yi
Yang, Stephen Shei-Dei
Jaw, Fu-Shan
Chang, Shang-Jen
author_sort Lo, Chi-Wen
collection PubMed
description The American Urological Association guidelines for the management of non-neurogenic overactive bladder (OAB) recommend the use of OnabotulinumtoxinA, sacral neuromodulation (SNM), and peripheral tibial nerve stimulation (PTNS) as third line treatment options with no treatment hierarchy. The current study used network meta-analysis to compare the efficacy of these three modalities for managing adult OAB syndrome. We performed systematic literature searches of several databases from January 1995 to September 2019 with language restricted to English. All randomized control trials that compared any dose of OnabotulinumtoxinA, SNM, and PTNS with each other or a placebo for the management of adult OAB were included in the study. Overall, 17 randomized control trials, with a follow up of 3–6 months in the predominance of trials (range 1.5–24 months), were included for analysis. For each trial outcome, the results were reported as an average number of episodes of the outcome at baseline. Compared with the placebo, all three treatments were more efficacious for the selected outcome parameters. OnabotulinumtoxinA resulted in a higher number of complications, including urinary tract infection and urine retention. Compared with OnabotulinumtoxinA and PTNS, SNM resulted in the greatest reduction in urinary incontinence episodes and voiding frequency. However, comparison of their long-term efficacy was lacking. Further studies on the long-term effectiveness of the three treatment options, with standardized questionnaires and parameters are warranted.
format Online
Article
Text
id pubmed-7077313
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-70773132020-03-20 Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis Lo, Chi-Wen Wu, Mei-Yi Yang, Stephen Shei-Dei Jaw, Fu-Shan Chang, Shang-Jen Toxins (Basel) Review The American Urological Association guidelines for the management of non-neurogenic overactive bladder (OAB) recommend the use of OnabotulinumtoxinA, sacral neuromodulation (SNM), and peripheral tibial nerve stimulation (PTNS) as third line treatment options with no treatment hierarchy. The current study used network meta-analysis to compare the efficacy of these three modalities for managing adult OAB syndrome. We performed systematic literature searches of several databases from January 1995 to September 2019 with language restricted to English. All randomized control trials that compared any dose of OnabotulinumtoxinA, SNM, and PTNS with each other or a placebo for the management of adult OAB were included in the study. Overall, 17 randomized control trials, with a follow up of 3–6 months in the predominance of trials (range 1.5–24 months), were included for analysis. For each trial outcome, the results were reported as an average number of episodes of the outcome at baseline. Compared with the placebo, all three treatments were more efficacious for the selected outcome parameters. OnabotulinumtoxinA resulted in a higher number of complications, including urinary tract infection and urine retention. Compared with OnabotulinumtoxinA and PTNS, SNM resulted in the greatest reduction in urinary incontinence episodes and voiding frequency. However, comparison of their long-term efficacy was lacking. Further studies on the long-term effectiveness of the three treatment options, with standardized questionnaires and parameters are warranted. MDPI 2020-02-18 /pmc/articles/PMC7077313/ /pubmed/32085542 http://dx.doi.org/10.3390/toxins12020128 Text en © 2020 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (http://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lo, Chi-Wen
Wu, Mei-Yi
Yang, Stephen Shei-Dei
Jaw, Fu-Shan
Chang, Shang-Jen
Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis
title Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis
title_full Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis
title_fullStr Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis
title_full_unstemmed Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis
title_short Comparing the Efficacy of OnabotulinumtoxinA, Sacral Neuromodulation, and Peripheral Tibial Nerve Stimulation as Third Line Treatment for the Management of Overactive Bladder Symptoms in Adults: Systematic Review and Network Meta-Analysis
title_sort comparing the efficacy of onabotulinumtoxina, sacral neuromodulation, and peripheral tibial nerve stimulation as third line treatment for the management of overactive bladder symptoms in adults: systematic review and network meta-analysis
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7077313/
https://www.ncbi.nlm.nih.gov/pubmed/32085542
http://dx.doi.org/10.3390/toxins12020128
work_keys_str_mv AT lochiwen comparingtheefficacyofonabotulinumtoxinasacralneuromodulationandperipheraltibialnervestimulationasthirdlinetreatmentforthemanagementofoveractivebladdersymptomsinadultssystematicreviewandnetworkmetaanalysis
AT wumeiyi comparingtheefficacyofonabotulinumtoxinasacralneuromodulationandperipheraltibialnervestimulationasthirdlinetreatmentforthemanagementofoveractivebladdersymptomsinadultssystematicreviewandnetworkmetaanalysis
AT yangstephensheidei comparingtheefficacyofonabotulinumtoxinasacralneuromodulationandperipheraltibialnervestimulationasthirdlinetreatmentforthemanagementofoveractivebladdersymptomsinadultssystematicreviewandnetworkmetaanalysis
AT jawfushan comparingtheefficacyofonabotulinumtoxinasacralneuromodulationandperipheraltibialnervestimulationasthirdlinetreatmentforthemanagementofoveractivebladdersymptomsinadultssystematicreviewandnetworkmetaanalysis
AT changshangjen comparingtheefficacyofonabotulinumtoxinasacralneuromodulationandperipheraltibialnervestimulationasthirdlinetreatmentforthemanagementofoveractivebladdersymptomsinadultssystematicreviewandnetworkmetaanalysis